Trials / Completed
CompletedNCT01116882
Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings
A Randomized Trial to Compare Percutaneous Coronary Intervention Between Massachusetts Hospitals With Cardiac Surgery-On-Site and Community Hospitals Without Cardiac Surgery-On-Site
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 3,691 (actual)
- Sponsor
- Baim Institute for Clinical Research · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the trial is to compare the acute safety and long term outcomes between hospitals with cardiac surgery on-site (SOS hospitals) and hospitals without cardiac surgery on-site (non-SOS hospitals) for patients with ischemic heart disease treated with elective percutaneous coronary intervention (PCI) (stable angina, acute coronary syndrome, or non-Q wave MI) presenting to non-SOS hospitals.
Detailed description
The MASS COMM trial is a prospective, multi-center, randomized, controlled two-arm trial of PCI performed at non-SOS hospitals (non-SOS-PCI arm) versus PCI performed at SOS hospitals (SOS-PCI arm). The trial is designed to reject the null-hypothesis of inferiority, and thereby show the non-inferiority of the non-SOS-PCI arm to the SOS-PCI arm. Specifically, 3690 subjects will be enrolled in a multi-center, randomized, controlled trial (RCT), in which eligible subjects will be consented and randomized in a 3:1 ratio at the non-SOS hospitals for PCI to be performed at either the enrolling non-SOS hospital (3 chances out of 4) or a corresponding SOS hospital (1 chance out of 4).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PCI |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2012-06-01
- Completion
- 2012-12-01
- First posted
- 2010-05-05
- Last updated
- 2015-04-07
- Results posted
- 2014-07-08
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01116882. Inclusion in this directory is not an endorsement.